Department of Chemistry and Biochemistry, University of Texas at Arlington, TX 76019, USA.
Institute of Analytical Sciences, University of Lyon 1, CNRS, Villeurbanne 69100, France.
J Pharm Biomed Anal. 2024 Dec 15;251:116420. doi: 10.1016/j.jpba.2024.116420. Epub 2024 Aug 16.
1,4-dihydropyridine (DHP) scaffold occupies a prominent position among all heterocyclic compounds owing to its versatile pharmacological properties, particularly its well-known calcium channel blocking activity. In the quest of developing new calcium channel blockers, fifty seven 5-oxo-hexahydroquinoline (HHQ) derivatives carrying DHP framework in a condensed ring system were recently synthesized as racemic mixtures. Due to their potential as drug candidates, enantiomers arising from the asymmetric center at the C-4 position of the HHQ ring were separated. Four modern columns packed with 2.7 µm superficially porous particles bonded with a chiral selector were used. The chiral selectors were three macrocyclic glycopeptide selectors: vancomycin, teicoplanin, and a macrocyclic derivative called nico. The fourth bonded selector was the dinitrobenzamido-tetrahydrophenanthrenyl derivative called Whelko. The four chromatographic modes were assayed with the mobile phase compositions: reversed phase with acetonitrile/buffer 30/70 %v/v, normal phase with hexane/ethanol 80/20 %v/v, and subcritical fluid chromatography with CO/methanol 80/20 %v/v at 25 °C. The WhelkoShell column was the most effective in separating this set of 57 compounds. Several enantioresolution factors passed 20 with enantioselectivity ratios higher than 4. Molecular modeling showed that the compounds had a T-shape that fitted well the molecular structure of the WhelkoShell selector in the normal or subcritical modes. Additionally, seven compounds had a second chiral center. The NicoShell column was able to separate all four stereoisomers of these compounds in the reversed phase mode. The preparative production of pure enantiomers of these compounds would be straightforward using the WhelkoShell column in the subcritical mode.
1,4-二氢吡啶(DHP)支架在所有杂环化合物中占有突出地位,因为它具有多种药理学特性,特别是其众所周知的钙通道阻断活性。在开发新的钙通道阻滞剂的过程中,最近合成了 57 个带有 DHP 骨架的 5-氧代-六氢喹啉(HHQ)衍生物,作为外消旋混合物。由于它们作为候选药物的潜力,从 HHQ 环的 C-4 位置的不对称中心产生的对映异构体被分离出来。使用了四个填充有 2.7µm 表面多孔颗粒的现代色谱柱,这些颗粒键合有手性选择器。手性选择器是三种大环糖肽选择器:万古霉素、替考拉宁和一种称为 nico 的大环衍生化合物。第四个键合选择器是称为 Whelko 的二硝基苯甲酰胺-四氢菲衍生物。使用以下流动相组成测试了四种色谱模式:反相模式,乙腈/缓冲液 30/70%v/v;正相模式,己烷/乙醇 80/20%v/v;亚临界流体色谱模式,CO/甲醇 80/20%v/v,温度为 25°C。WhelkoShell 柱在分离这 57 种化合物的一组中最有效。几个对映体拆分因子超过 20,对映选择性比高于 4。分子模拟表明,这些化合物具有 T 形结构,非常适合 WhelkoShell 选择器在正相或亚临界模式下的分子结构。此外,有七个化合物具有第二个手性中心。NicoShell 柱能够在反相模式下分离这些化合物的所有四个立体异构体。使用 WhelkoShell 柱在亚临界模式下,这些化合物的纯对映异构体的制备生产将非常简单。